![Charles Olson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Olson
Chief Tech/Sci/R&D Officer at
NERVGEN PHARMA CORP.
Net worth: 23 163 $ as of 2026-09-29
Profile
Charles V.
Olson currently serves as Independent Director at Edesa Biotech, Inc. since 2023, President at Alkira Therapeutics, Inc., and Senior Vice President-Technical Operations at NervGen Pharma Corp.
Former positions include Director-Manufacturing Sciences at Onyx Pharmaceuticals, Inc., Senior Director-Manufacturing at BioMarin Pharmaceutical, Inc., Independent Director at Stellar Biotechnologies, Inc. from 2016 to 2019, Vice President-Hayward Operations at Cell Genesys, Inc., Chief Operating Officer at Dendreon Corp.
from 2021 to 2023, Chief Technology Officer at Anthera Pharmaceuticals, Inc. from 2016 to 2017, Vice President-CMC & Technical Operations at NGM Biopharmaceuticals, Inc., Senior Vice President-Product & Operations at Ansun Biopharma, Inc., and Senior Vice President-Operations at Applied Molecular Transport, Inc. from 2019 to 2022.
Education includes graduate studies at the University of California, Santa Barbara, undergraduate studies at Westmont College, and a doctorate from Hawthorn University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EDESA BIOTECH, INC. 0.04% | 2026-05-26 | 5,502 ( 0.04% ) | 23 163 $ | 2026-09-29 |
Charles Olson active positions
| Companies | Position | Start |
|---|---|---|
| EDESA BIOTECH, INC. | Director/Board Member | 2023-05-22 |
| NERVGEN PHARMA CORP. | Chief Tech/Sci/R&D Officer | - |
Alkira Therapeutics, Inc.
 Alkira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes clinical pharmaceutical products | President | - |
Former positions of Charles Olson
| Companies | Position | End |
|---|---|---|
| DENDREON CORPORATION | Chief Operating Officer | 2023-03-31 |
| APPLIED MOLECULAR TRANSPORT INC. | Chief Operating Officer | 2022-05-15 |
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops biological products for biomedical applications specializing in the production of GMP-grade keyhole limpet hemocyanin | Director/Board Member | 2019-05-31 |
| ANTHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2017-07-12 |
Ansun Biopharma, Inc.
 Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Education of Charles Olson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Westmont College
 Westmont College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops biological products for biomedical applications specializing in the production of GMP-grade keyhole limpet hemocyanin | Health Technology |
Alkira Therapeutics, Inc.
Alkira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes clinical pharmaceutical products | Health Technology |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Hawthorn University
 Hawthorn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Edesa Biotech, Inc.
 Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
- Stock Market
- Insiders
- Charles Olson
